SNPMiner Trials by Shray Alag


SNPMiner Trials: Clinical Trial Report


Report for Clinical Trial NCT00364728

Developed by Shray Alag, 2019.
SNP Clinical Trial Gene

Efferocytosis (Clearance of Apoptotic Cells by Phagocytosis) and Autoimmune Diseases in Human

Over the past few years, growing evidences revealed that clearance of apoptotic cells by phagocytosis can result in powerful anti-inflammatory and immunosuppressive effects. In vivo, apoptotic cells are cleared rapidly by neighboring cells, macrophages and related scavengers. Defective clearance of apoptotic cells has been linked closely to autoimmunity and persistent inflammatory disease. Several phagocytic receptors, bridging molecules produced by phagocytes and 'eat-me' signals on apoptotic cells are coordinately involved in mediating clearance of apoptotic cells. Complement receptors (CR3, CR4), collection, CD14, CD36 (Class B scavenger receptor), class A scavenger receptor, asialoprotein receptor, Mer receptor kinase were reported to recognize apoptotic cells. The best characterized system for clearance of apoptotic cells is the recognition of phosphatidylserine (PS) on apoptotic cells by phosphatidylserine receptor (PSR). Milk fat globule- epidermal growth factor 8 (MFG-E8) is an opsonin that bridges phagocytes (by interacting with α vβ3, αvβ5 integrins via RGD motif) and apoptotic cells (by binding PS through Factor V/VIII-C domain). Activated macrophages produce and secret MFG-E8. MFG-E8 is a critical component in PSR-mediated phagocytosis of apoptotic cells. The dominant negative mutant MFG-E8, D89E, that carried a mutated RGD motif inhibited phagocytosis of apoptotic cells in vitro. Injection of D89E into wild type mice induced autoantibodies and IgG deposition on glomeruli. Macrophages from MFG-E8 deficiency (MFG-E8-/-) mice were impaired in engulfment of apoptotic cells, which can be restored by adding recombinant MFG-E8. The female MFG-E8-/- mice spontaneously produced high titer of autoantibodies and developed lupus-like glomerulonephritis at the age of week 40. Defective clearance of apoptotic cells is closely related to development of autoimmunity. In the past 4 years, a growing number of molecules were recognized as receptors for the PS exposed on the apoptotic cells. These molecules were capable of mediating phagocytic clearance, rendering anti-inflammatory cytokines in the phagocytes, and modulating T cell responses. The specific aim of this proposal is to study genetic polymorphism in MFG-E8, PSR and other factors implicated in phagocytic clearance of apoptotic cells among Taiwanese. By comparing the polymorphism between patients with autoimmune disease (SLE or RA) and healthy control subjects, we will investigate if genetic variations among individuals of genes encoding proteins involved in clearance of apoptotic cells contribute to the pathogenesis of systemic autoimmune diseases SLE and RA.

NCT00364728 SLE Rheumatoid Arthritis Healthy Subjects
MeSH: Arthritis, Rheumatoid Autoimmune Diseases
HPO: Autoimmunity Rheumatoid arthritis



Time Perspective: Retrospective

Case Control


There is one SNP

SNPs


1 D89E

The dominant negative mutant MFG-E8, D89E, that carried a mutated RGD motif inhibited phagocytosis of apoptotic cells in vitro. --- D89E ---

Injection of D89E into wild type mice induced autoantibodies and IgG deposition on glomeruli. --- D89E ---

Kenichi et al. showed that masking phosphatidylserine by MFG-E8 mutant D89E, carrying a point mutation in RGD motif, inhibited not only the phagocytosis of apoptotic cells by macrophages of different origins but also the production of IL10 by thioglycollate-elicited peritoneal macrophages after phagocytosing apoptotic cells. --- D89E ---

When D89E MFG-E8 was injected into wild type mice intravenously, auto-antibodies were induced. --- D89E ---



HPO Nodes


HPO:
Autoimmunity
Genes 140
RNASEH2B KRAS TPP2 IL12A RAG1 RAG2 IL12RB1 TREX1 TCF4 GALC ITCH PRTN3 NRAS WAS COMT WIPF1 SPIB TNFSF12 RNASEH2A HLA-DPA1 GPR35 HLA-DPB1 HLA-DQB1 HLA-DRB1 POLG ACP5 KIAA0319L PEPD FADD AIRE TCIRG1 SRP54 OAS1 POU2AF1 CASP10 NBN NLRP1 PTPN22 IRF5 SAMHD1 TRAC CHD7 LMNB2 CAV1 LCK RREB1 SLC7A7 PTEN FAS ADA FASLG CR2 ADAR ADA2 RFX5 RFXAP ANKRD55 JMJD1C ZAP70 GFI1 STAT1 ITK STAT3 STAT4 HIRA TTC7A STIM1 IFNGR1 MST1 RMRP IFIH1 PTPN2 RASGRP1 LIG4 FCGR2C C1GALT1C1 CD3G KMT2D CD247 ICOS MMEL1 CSF2RA CSF2RB SLC12A3 SEC24C CD19 MS4A1 CLCNKB ARVCF CIITA DCLRE1C LACC1 MTHFD1 PIK3R1 RFXANK NFKB1 BTK NFKB2 RNASEH2C UFD1 MIF TNFRSF13C SERPING1 ELANE TNFRSF13B C1QA C1QB C1QC C1R C1S PRKCD C2 C3 CD81 C4A CCN2 CCR6 CTLA4 PLCG2 TNFAIP3 MMP2 C8A LRBA NHEJ1 IL2RA IL2RB IL2RG KDM6A TNFSF15 TNPO3 DNASE1L3 IL6 SEC23B TBX1 IL7R MASP2 GP1BB PNP TBX2 FOXP3
Rheumatoid arthritis
Genes 14
DCLRE1C IL2RA IL2RB LACC1 PTPN2 ANKRD55 PTPN22 IL6 GCH1 HLA-DRB1 ACP5 CD247 STAT4 MIF